|
|
|
|
| LEADER |
01727nam a2200289 u 4500 |
| 001 |
EB001839264 |
| 003 |
EBX01000000000000001003253 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a Pregabalin for acute pain
|h Elektronische Ressource
|b a review of the clinical effectiveness
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 24 January 2017, 2017
|
| 300 |
|
|
|a 1 PDF file (16 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Pregabalin / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Acute Pain / drug therapy
|
| 653 |
|
|
|a Pain Management / methods
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report: summary with critical appraisal
|
| 500 |
|
|
|a "CADTH Rapid Response Service."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK442133
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Current pharmacotherapeutic options for the management of acute pain, specifically opioids, can be associated with potential harms.1,2 New therapeutic options are necessary to optimize the management of acute pain secondary to various causes. The objective of this report is to review the evidence for clinical effectiveness of pregabalin compared to placebo in the management of acute non-operative pain, and pregabalin in combination with opioids compared to opioids alone in the management of acute and post-operative pain
|